Terns Pharmaceuticals, Inc. (TERN)

NMS – Real Time Price. Currency in USD

52.95

+52.95 (0.00%)

At close: May 4, 2026, 4:00 PM EDT

05.05.2026

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the successful completion of the acquisition of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN). “The Terns acquisition reflects Merck's continued focus on science‑driven, value‑enhancing business development aimed at bringing meaningful innovation to patients,” said Robert M. Davis, chairman and chief executive officer, Merck. “We believe TERN‑701 has the potential to be.

27.04.2026

Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?

Merck MRK is set to report its first-quarter 2026 earnings on April 30, before market open. The Zacks Consensus Estimate for first-quarter top line is pegged at $15.90 billion, while the same for the bottom line stands at a loss of $1.51 per share.

27.04.2026

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Designation for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase (CP) without the T315I mutation previously treated with two or more tyrosine kinase inhibitors (TKIs) Designation for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in the chronic phase (CP) without the T315I mutation previously treated with two or more tyrosine kinase inhibitors (TKIs)

24.04.2026

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (“HSR”), in connection with Merck's pending acquisition of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN) expired at 11:59 p.m., Eastern Time, on April 23, 2026. As previously announced on April 7, 2026, Merck commenced, through a subsidiary, a cash tender offer to purchase.

15.04.2026

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.

10.04.2026

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Terns Pharmaceuticals, Inc. (NasdaqGS: TERN) to Merck (NYSE: MRK). Under the terms of the proposed transaction, shareholders of Terns will receive $53.00 in cash for each share of Terns that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate,.

08.04.2026

Why Terns Pharmaceuticals Stock Rocked the Market in March

All told, the transaction is valued at around $6.7 billion. If all goes well, it'll close this quarter.

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

24.04.2026

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

15.04.2026

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers.

Terns Pharmaceuticals, Inc. (TERN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Terns Pharmaceuticals, Inc. (TERN)

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Why Terns Pharmaceuticals Stock Rocked the Market in March

Videos

Press releases

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Why Terns Pharmaceuticals Stock Rocked the Market in March

Videos

Press releases

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Search stocks

Terns Pharmaceuticals, Inc. (TERN)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Terns Pharmaceuticals, Inc. (TERN)

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Why Terns Pharmaceuticals Stock Rocked the Market in March

Videos

Press releases

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Buy, Sell or Hold MRK Stock With Q1 Earnings Around the Corner?

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?

Terns Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Terns Pharmaceuticals, Inc. - TERN

Why Terns Pharmaceuticals Stock Rocked the Market in March

Videos

Press releases

Merck Completes Acquisition of Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals Announces FDA Breakthrough Therapy Designation Granted to TERN-701 for Certain Patients with Chronic Myeloid Leukemia

Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.

Are TERN, SLNO, WSR Obtaining Fair Deals for their Shareholders?